Select Page

Anti-CD11b (Human/Mouse) mAb-PE-Cy7 (Monoclonal Antibody)

This product is only available in the US
FP10117702
Antibody
25 µg

THIS ITEM HAS BEEN DISCONTINUED

DATA SHEET

The M1/70 monoclonal antibody specifically reacts with the 170 kDa αM integrin chain of mouse CD11b from the Mac-1 integrin (CD11b/CD18). Mac-1 binds to C3bi, CD54 (ICAM-1), and fibrinogen, and it is expressed by granulocytes, macrophages, NK cells, myeloid-derived dendritic cells, microglia, activated lymphocytes, and mouse B-1 cells. The expression is up-regulated on activated neutrophils at the same time that L-selectin is shed from the cell surface. The M1/70 antibody is used for the detection of monocytes, granulocytes, and a subset of natural killer cells in human peripheral blood.

M1/70 blocks C3bi binding and cell adherence, but not cell-mediated lysis and it cross-reacts with human CD11b.

Application Notes:

The antibody has been analyzed for quality through the flow cytometric analysis of the relevant cell type. For flow cytometric staining, the suggested use of this reagent is ≤0.125 ug per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

TargetCD11b
Product TypeAntibody
ApplicationFCM
ClonalityMonoclonal
ConjugatePE
IsotypeIgG2b ĸ
Host SpeciesRat
Species ReactivityHuman, Mouse
FormulationPhosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.
Research AreaImmunology, Angiogenesis, Flow Cytometry, Innate Immunity
Storage TemperatureThe product should be stored undiluted at 4°C and should be protected from prolonged exposure to light. Do not freeze.The monoclonal antibody was purified utilizing affinity chromatography and unreacted dye was removed from the product.
ProtocolsFCM
Clone NumberM1/70
Concentration0.2 mg/mL
Regulatory StatementFor Research Use Only. Not for use in diagnostic procedures.
This product is only available in the US
FP10117702
Antibody
25 µg

THIS ITEM HAS BEEN DISCONTINUED

Related Content

SIGN UP